Peptides for Weight Loss: What to Know, According to Experts


These five peptide-containing medications have been shown to help people lose weight.

preview for How to Build a Balanced Breakfast

We may earn commission from links on this page, but we only recommend products we back.

Medications like Wegovy and Zepbound receive plenty of buzz for their ability to help people lose weight. The two have a few things in common, mainly, peptides for weight loss. Wegovy (semaglutide) belongs to a class of medications known as glucagon-like peptide-1 (GLP-1), and Zepbound (tirzepatide) is both a GLP-1 and glucose-dependent insulinotropic polypeptide (GIP).

But here’s the thing: Not all peptides are designed for weight loss, although research has found that it’s usually a common side effect. A good example is Ozempic, which has become popular for medicated weight loss, despite technically being a drug to help with blood sugar management in patients with type 2 diabetes.

Meet the experts: Keri Gans, R.D., author of The Small Change Diet; Christoph Buettner, M.D., Ph.D., is chief of the division of endocrinology at Rutgers Robert Wood Johnson Medical School; Mir Ali, M.D., is a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA.

If you’re interested in using peptides for weight loss, there are options. Here’s what you need to know about the types of peptides, how each works, and potential side effects to keep in mind.

What are peptides?

You may have heard of peptide serums for healthy skin, and that’s because the ingredient is in so many things. “Peptides are a string of amino acids structurally similar to protein but smaller,” says Keri Gans, R.D., author of The Small Change Diet. Peptides usually contain less than 50 amino acid chains, says Christoph Buettner, M.D., Ph.D., chief of the division of endocrinology at Rutgers Robert Wood Johnson Medical School.

“Peptides play crucial roles in various biological processes within the body, acting as signaling molecules, hormones, and enzymes,” Dr. Buettner says. “There are thousands of peptides in our body doing many different things.”

Do peptides work for weight loss?

Yes, peptides can work for weight loss—but not all peptides will impact the number on the scale. “Asking if peptides can be used for weight loss is akin to asking whether drugs can be used for weight loss,” Dr. Buettner says. “There are a gazillion drugs that cannot be used for weight loss, but then there are some that can. The same applies to peptides.”

Peptides that work for weight loss will usually slow the movement of food through the gut and reduce cravings among other things, says Mir Ali, M.D., a bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA.

What types of peptides work for weight loss?

There are a bunch. “GLP-1 receptor agonist medications are formulated to stimulate peptide production in the body to slow stomach emptying,” Dr. Ali says. “Dual GIP/GLP-1 receptor agonists are involved in digestion, hunger, and satiety.”

“Both of these hormones/peptides are attractive candidates for weight management,” Dr. Buettner says.

Several peptides can work for weight loss, but these are the most common ones on the market right now:

  • Semaglutide (Ozempic, Wegovy). Semaglutide is a GLP-1 receptor agonist and includes Ozempic (which, again, is designed to treat type 2 diabetes) and obesity (Wegovy). Both are injectable medications approved by the Food and Drug Administration (FDA). The Ozempic website points out that people on the drug have lost up to 14 pounds, but also stresses that it’s “not a weight loss drug.” The Wegovy website also says that adults on average lose about 15% of their body weight or 35 pounds on the medication—and this one is approved for weight loss.
  • Tirzepetide (Mounjaro, Zepbound). This medication is a GLP-1/GIP receptor agonist, which essentially means it’s similar to semaglutide but targets an additional receptor in the body (GIP), Dr. Ali explains. These medications include Mounjaro, which is FDA-approved to treat type 2 diabetes, and Zepbound, which is designed for weight loss. The Zepbound website says that people lost up to 48 pounds during a 17-month clinical trial.
  • Liraglutide (Saxenda). Sold under the name Saxenda, Liraglutide is a GLP-1 receptor agonist that’s approved for weight loss. Research has found that one out of three people who take Saxenda lost more than 10% of their body weight.

“There are others that are not as well studied and regulated that are sold as supplements,” Dr. Ali says. So be sure to do your research before considering any that are not FDA-approved, and consult your doctor before starting a new weight loss regimen.

Do you need a prescription to get peptides for weight loss?

In order to use peptides that are FDA-approved for weight loss, you need a prescription. There are also some specifics for each drug to indicate if you would be a good candidate.

Zepbound, for example, is designed for people with overweight (which is considered as a BMI of 27 or above) or obesity (a BMI of 30 or above) who also have one or more weight-related conditions like type 2 diabetes, high blood pressure, or high cholesterol. Wegovy also has similar requirements.

Potential side effects of using peptides for weight loss

Every peptide medication for weight loss is different and it’s important to talk to your doctor about the pros and cons of each before deciding on one. However, some common side effects can happen with these medications, and they usually involve the gastrointestinal tract, Dr. Ali says. Those can include:

  • Nausea
  • Cramping
  • Constipation
  • Diarrhea

“They tend to be fairly limited and resolve with time,” Dr. Ali says. That’s why the medications are started at a lower dose and ramped up to higher doses with time, he says.

Other potential side effects, per Dr. Buettner, include:

  • Low blood sugar
  • Injection site reactions like redness, swelling, or pain
  • Headache
  • Dizziness
  • Fatigue

Usually, once your body gets used to the medications, the side effects stop, Dr. Buettner says. But, for some (note: rare) cases, some may experience:

If you’re interested in taking a peptide for weight loss, talk to your doctor. They should be able to help guide you through your options.

Peptides on Stardust May Have Provided a Shortcut to Life


The discovery that short peptides can form spontaneously on cosmic dust hints at more of a role for them in the earliest stages of life’s origin, on Earth or elsewhere.

READ LATER
An illustration of a polyglycine molecule among the constellations.
The spontaneous formation of peptide molecules on cosmic dust in interstellar clouds could have implications for theories about the origin of life.Kristina Armitage / Quanta Magazine

Yasemin Saplakoglu

Billions of years ago, some unknown location on the sterile, primordial Earth became a cauldron of complex organic molecules from which the first cells emerged. Origin-of-life researchers have proposed countless imaginative ideas about how that occurred and where the necessary raw ingredients came from. Some of the most difficult to account for are proteins, the critical backbones of cellular chemistry, because in nature today they are made exclusively by living cells. How did the first protein form without life to make it?

Scientists have mostly looked for clues on Earth. Yet a new discovery suggests that the answer could be found beyond the sky, inside dark interstellar clouds.

Last month in Nature Astronomy, a group of astrobiologists showed that peptides, the molecular subunits of proteins, can spontaneously form on the solid, frozen particles of cosmic dust drifting through the universe. Those peptides could in theory have traveled inside comets and meteorites to the young Earth — and to other worlds — to become some of the starting materials for life.

The simplicity and favorable thermodynamics of this new space-based mechanism for forming peptides make it a more promising alternative to the known purely chemical processes that could have occurred on a lifeless Earth, according to Serge Krasnokutski, the lead author on the new paper and a researcher at the Max Planck Institute for Astronomy and the Friedrich Schiller University in Germany. And that simplicity “suggests that proteins were among the first molecules involved in the evolutionary process leading to life,” he said.

Researchers say they’ve found a shortcut to proteins — a simpler chemical pathway that reenergizes the theory that proteins were present very early in the genesis of life.

Whether those peptides could have survived their arduous trek from space and contributed meaningfully to the origin of life is very much an open question. Paul Falkowski, a professor at the School of Environmental and Biological Sciences at Rutgers University, said that the chemistry demonstrated in the new paper is “very cool” but “doesn’t yet bridge the phenomenal gap between proto-prebiotic chemistry and the first evidence of life.” He added, “There’s a spark that’s still missing.”

Still, the finding by Krasnokutski and his colleagues shows that peptides might be a much more readily available resource throughout the universe than scientists believed, a possibility that could also have consequences for the prospects for life elsewhere.

Cosmic Dust in a Vacuum

Cells make the production of proteins look easy. They manufacture both peptides and proteins extravagantly, empowered by environments rich in useful molecules like amino acids and their own stockpiles of genetic instructions and catalytic enzymes (which are themselves typically proteins).

But before cells existed, there wasn’t an easy way to do it on Earth, Krasnokutski said. Without any of the enzymes that biochemistry provides, the production of peptides is an inefficient two-step process that involves first making amino acids and then removing water as the amino acids link up into chains in a process called polymerization. Both steps have a high energy barrier, so they occur only if large amounts of energy are available to help kick-start the reaction.

Because of these requirements, most theories about the origin of proteins have either centered on scenarios in extreme environments, such as near hydrothermal vents on the ocean floor, or assumed the presence of molecules like RNA with catalytic properties that could lower the energy barrier enough to push the reactions forward. (The most popular origin-of-life theory proposes that RNA preceded all other molecules, including proteins.) And even under those circumstances, Krasnokutski says that “special conditions” would be needed to concentrate the amino acids enough for polymerization. Though there have been many proposals, it isn’t clear how and where those conditions could have arisen on the primordial Earth.

But now researchers say they’ve found a shortcut to proteins — a simpler chemical pathway that reenergizes the theory that proteins were present very early in the genesis of life.

An illustration of a polyglycine molecule among the constellations.

Last year in Low Temperature Physics, Krasnokutski predicted through a series of calculations that a more direct way to make peptides could exist under the conditions available in space, inside the extremely dense and frigid clouds of dust and gas that linger between the stars. These molecular clouds, the nurseries of new stars and solar systems, are packed with cosmic dust and chemicals, some of the most abundant of which are carbon monoxide, atomic carbon and ammonia.

In their new paper, Krasnokutski and his colleagues showed that these reactions in the gas clouds would likely lead to the condensation of carbon onto cosmic dust particles and the formation of small molecules called aminoketenes. These aminoketenes would spontaneously link up to form a very simple peptide called polyglycine. By skipping the formation of amino acids, reactions could proceed spontaneously, without needing energy from the environment.

To test their claim, the researchers experimentally simulated the conditions found in molecular clouds. Inside an ultrahigh vacuum chamber, they mimicked the icy surface of cosmic dust particles by depositing carbon monoxide and ammonia onto substrate plates chilled to minus 263 degrees Celsius. They then deposited carbon atoms on top of this ice layer to simulate their condensation inside molecular clouds. Chemical analyses confirmed that the vacuum simulation had indeed produced various forms of polyglycines, up to chains 10 or 11 subunits long.

The researchers hypothesized that billions of years ago, as cosmic dust stuck together and formed asteroids and comets, simple peptides on the dust could have hitchhiked to Earth in meteorites and other impactors. They might have done the same on countless other worlds, too.

The Gap From Peptides to Life

The delivery of peptides to Earth and other planets “certainly would provide a head start” to forming life, said Daniel Glavin, an astrobiologist at NASA’s Goddard Space Flight Center. But “I think there’s a large jump to go from interstellar ice dust chemistry to life on Earth.”

First the peptides would have to endure the perils of their journey through the universe, from radiation to water exposure inside asteroids, both of which can fragment the molecules. Then they’d have to survive the impact of hitting a planet. And even if they made it through all that, they would still have to go through a lot of chemical evolution to get large enough to fold into proteins that are useful for biological chemistry, Glavin said.

Is there evidence that this has happened? Astrobiologists have discovered many small molecules including amino acids inside meteorites, and one study from 2002 discovered that two meteorites held extremely small, simple peptides made from two amino acids. But researchers have yet to discover other convincing evidence for the presence of such peptides and proteins in meteorites or samples returned from asteroids or comets, Glavin said. It’s unclear if the nearly total absence of even relatively small peptides in space rocks means that they don’t exist or if we just haven’t detected them yet.

But Krasnokutski’s work could encourage more scientists to really start looking for these more complex molecules in extraterrestrial materials, Glavin said. For example, next year NASA’s OSIRIS-REx spacecraft is expected to bring back samples from the asteroid Bennu, and Glavin and his team plan to look for some of these types of molecules.

The researchers are now planning to test whether bigger peptides or different types of peptides can form in molecular clouds. Other chemicals and energetic photons in the interstellar medium might be able to trigger the formation of larger and more complex molecules, Krasnokutski said. Through their unique laboratory window into molecular clouds, they hope to witness peptides getting longer and longer, and one day folding, like natural origami, into beautiful proteins that burst with potential.

AI is like having a treasure map to find disease-preventing molecules – Dr Nora Khaldi


Dr Nora Khladi hopes that by using peptide molecules we will be able to prevent future chronic disease.

A cereal bar that keeps diabetes at bay is one example of how we could prevent disease by adding short molecules known as peptides into what we eat, says Dr Nora Khaldi, founder of Nuritas, which is using artificial intelligence (AI) to identify new peptides and create foods with health benefits.

What are peptides and why are scientists interested in studying them?

‘Peptides are molecules that exist everywhere – every single species of animal and plant has peptides. In humans, the body uses these molecules to communicate internally. They are the building blocks of everything. But in some diseases, there may be too much or too little of a particular peptide. By modulating peptides you can help to prevent or cure a disease.

‘There are around 60 peptides commercially available at present, including some very familiar products. Insulin is a peptide and is used to control diabetes, growth factors (which stimulate cell growth) are peptides and so is penicillin. Many of the everyday molecules produced in the pharmaceutical sector are either small molecules, peptides or proteins – proteins are just a larger version of peptides.’

There are billions of peptides – why are so few used to improve health?

‘Identifying and testing peptides is very expensive and time-consuming, making this field the preserve of larger pharmaceutical companies. Nuritas, the company I founded, is making it faster and cheaper to find peptides that have health benefits. We’re democratising peptides.’

How are you using AI to make this happen?

‘AI has accelerated this whole process dramatically, allowing us to do in a few months what has previously taken years and millions of euros to achieve. The old approach was tedious – there are so many peptides that finding the one which solves a major health problem was a long shot.

‘We’re democratising peptides.’

Dr Nora Khaldi, Founder, Nuritas

‘It was like knowing there’s a treasure chest buried somewhere in the ocean but having no map. You’d spend years and millions of euros and might still find nothing. Our technology is like having access to a map. We can analyse the molecules, figure out what they do in the body and determine how easy it is to unlock them from a food source.

‘For me, as someone with a background in pure maths and computer science, I see this as a data problem more than a biological or chemical problem.’

With so many potentially valuable peptides, where does the search begin?

‘We are interested in two types of peptide: we make synthetic peptides for the pharma industry which may be used to cure disease. But we are also very interested in naturally occurring peptides that can be extracted from food and used for disease prevention. Grains and vegetables are an important focus – we want to look for peptides in foods that people have always eaten because these are unlikely to be toxic to us and are readily available. It’s not like a rare plant or an exotic herb – these are everyday foods.’

If you can find peptides in certain foods, why not just advise people to eat more of that food?

‘You don’t get the same benefit. The peptides are often locked inside a complex food structure. We use computers to study how to get it out of the food.’

Why is disease prevention a priority?

‘If you think about the whole health system, it’s completely broken. We spend 97 % (of healthcare budgets) on curing diseases and just 3 % on prevention. That has to change. There are too many people living with chronic diseases. Our goal should be to stop people in a pre-disease state from converting into a disease state. There’s no other way: our populations are growing and ageing so it will be impossible for governments to sustain our health systems. Prevention is the future.’

You’ve received EU funding via the PeptiEUForce project to look into how peptides can be used for diabetes prevention. Can you tell us about your work?

‘Today, if you have pre-diabetes the choice is to radically change your diet – which most people cannot do – or develop diabetes. Imagine if we could create a cereal bar with our Nuritas glucose-regulating peptide within that pre-diabetics could consume every day. One cereal bar a day, containing Nuritas active peptides that regulate blood sugar to normal levels, would be a viable option for people and reduce long-term spending on managing diabetes.

‘Diabetes is a huge area given the unmet need for prevention, but we are also looking at ways to control inflammatory diseases and (researching) other peptides that are linked to stress and cancer. Another exciting area is how we can use peptides to prevent muscle decline which is linked to reduced mobility in older people.’

How long before we see these products on our shelves?

‘The plan is for the diabetes product to hit the market in 2021. Trials are not as long as for pharma because the focus is on efficacy. These are natural peptides – food extracts – rather than synthetic chemicals used in pharmaceuticals, so we do double-blind placebo trials to show they are effective and as these ingredients are from safer, natural sources, it thus reduces the time to market substantially.

‘We are applying to the European Food Safety Authority (EFSA) for permission to make a health benefit claim about our food product. Very rigorous scientific proof is needed – I think EFSA has granted eight health claims in 10 years – but we believe we will hit the mark. We would love for this peptide to be the first scientifically proven diabetes active prevention via a functional food.’

Putting innovative ideas into practice

Small- and medium-sized enterprises (SMEs) with radically new ideas who want to scale up their activities can apply for funding through the Horizon 2020 programme. The EU has allocated EUR 1.6 billion to support SMEs between 2018 and 2020.

This money is available through the so-called SME Instrument, which is designed to help high-risk, high-potential SMEs turn innovative ideas into reality so that they can complete on the global market while creating European jobs.

Funding is available to individual companies and entrepreneurs at three different stages: feasibility studies, moving from concept to market, and business acceleration.